David Iberri is a Hematology physician affiliated with Stanford Medicine. OpenAlex indexes 43 publications with 873 citations (h-index 10); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant
Sponsor: Stanford University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
50.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor50.8%Acyclovir100%Part D≥18 patientsSensory organs
28.8%Corticosteroid28.8%Dexamethasone100%Part D<11 patientsAnti-infectives
20.3%Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor20.3%Entecavir100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Monoclonal versus monotypic: promoting awareness of terminology and clinical take-aways
Kidney International
2026 - First, do NOHARM: a medical safety benchmark and randomized study of physician and AI teaming on clinical consultations
arXiv (Cornell University)
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Teuteberg, MD
Stanford Medicine
Charles Debattista, MD
Stanford Medicine
Jong Yoon, MD
Stanford Medicine
Kimberly Dequattro, MD, MM
Stanford Medicine
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Jaroslaw Maciejewski, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”